BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19582427)

  • 1. Cancer stem cells in head and neck squamous cell carcinoma.
    Ailles L; Prince M
    Methods Mol Biol; 2009; 568():175-93. PubMed ID: 19582427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits.
    Oh SY; Kang HJ; Kim YS; Kim H; Lim YC
    Eur J Cancer; 2013 Jan; 49(1):272-80. PubMed ID: 22770891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures.
    Lim YC; Oh SY; Kim H
    Exp Cell Res; 2012 Jun; 318(10):1104-11. PubMed ID: 22426199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of head and neck squamous carcinoma cancer stem-like cells in a syngeneic mouse model and analysis of hypoxia effect.
    Duarte S; Loubat A; Momier D; Topi M; Faneca H; Pedroso de Lima MC; Carle GF; Pierrefite-Carle V
    Oncol Rep; 2012 Sep; 28(3):1057-62. PubMed ID: 22825753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.
    Prince ME; Sivanandan R; Kaczorowski A; Wolf GT; Kaplan MJ; Dalerba P; Weissman IL; Clarke MF; Ailles LE
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):973-8. PubMed ID: 17210912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
    Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
    In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of CD90+ cancer stem cells in human liver cancer.
    Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST
    Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
    Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R
    Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines.
    Kidwai F; Costea DE; Hutchison I; Mackenzie I
    J Oral Pathol Med; 2013 Oct; 42(9):682-90. PubMed ID: 23627635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness.
    Joshua B; Kaplan MJ; Doweck I; Pai R; Weissman IL; Prince ME; Ailles LE
    Head Neck; 2012 Jan; 34(1):42-9. PubMed ID: 21322081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of tumor heterogeneity--different phenotypes of cancer stem cells in a head and neck squamous cell carcinoma xenograft mouse model.
    Geißler C; Hambek M; Leinung M; Diensthuber M; Gassner D; Stöver T; Wagenblast J
    In Vivo; 2012; 26(4):593-8. PubMed ID: 22773573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes.
    Zhang P; Zhang Y; Mao L; Zhang Z; Chen W
    Cancer Lett; 2009 May; 277(2):227-34. PubMed ID: 19185988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stem cell hypothesis in head and neck cancer.
    Graziano A; d'Aquino R; Tirino V; Desiderio V; Rossi A; Pirozzi G
    J Cell Biochem; 2008 Feb; 103(2):408-12. PubMed ID: 17546610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
    Hildebrand LC; Carvalho AL; Lauxen IS; Nör JE; Cerski CT; Sant'Ana Filho M
    J Oral Pathol Med; 2014 Aug; 43(7):499-506. PubMed ID: 24527751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer.
    Abelson S; Shamai Y; Berger L; Shouval R; Skorecki K; Tzukerman M
    Stem Cells; 2012 Mar; 30(3):415-24. PubMed ID: 22267284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
    Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
    Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of gene expression in head and neck carcinoma using laser capture microdissection and real-time reverse transcription polymerase chain reaction.
    Malhotra PS; Malekfzali A; Bonner RF; Juhn S; Van Waes C; Chen Z
    Laryngoscope; 2004 Dec; 114(12):2123-8. PubMed ID: 15564832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
    Kurth I; Hein L; Mäbert K; Peitzsch C; Koi L; Cojoc M; Kunz-Schughart L; Baumann M; Dubrovska A
    Oncotarget; 2015 Oct; 6(33):34494-509. PubMed ID: 26460734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
    Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
    Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.